小鼠肝素酶H-2Kb限制性CTL表位的实验鉴定

汤旭东, 万瑛, 房殿春, 陈陵, 熊震, 余松涛, 师红磊, 郭军, 杨仕明

汤旭东, 万瑛, 房殿春, 陈陵, 熊震, 余松涛, 师红磊, 郭军, 杨仕明. 小鼠肝素酶H-2Kb限制性CTL表位的实验鉴定[J]. 实用临床医药杂志, 2008, (1): 5-11. DOI: 10.3969/j.issn.1672-2353.2008.01.002
引用本文: 汤旭东, 万瑛, 房殿春, 陈陵, 熊震, 余松涛, 师红磊, 郭军, 杨仕明. 小鼠肝素酶H-2Kb限制性CTL表位的实验鉴定[J]. 实用临床医药杂志, 2008, (1): 5-11. DOI: 10.3969/j.issn.1672-2353.2008.01.002
TANG Xu-dong, WAN Yin, FANG Dian-chun, CHEN Ling, XIONG Zhen, YU Song-tao, SHI Hong-lei, GUO Jun, YANG Shi-ming. Identification of H-2Kb-restricted CTL epitopes derived from Heparanase antigen[J]. Journal of Clinical Medicine in Practice, 2008, (1): 5-11. DOI: 10.3969/j.issn.1672-2353.2008.01.002
Citation: TANG Xu-dong, WAN Yin, FANG Dian-chun, CHEN Ling, XIONG Zhen, YU Song-tao, SHI Hong-lei, GUO Jun, YANG Shi-ming. Identification of H-2Kb-restricted CTL epitopes derived from Heparanase antigen[J]. Journal of Clinical Medicine in Practice, 2008, (1): 5-11. DOI: 10.3969/j.issn.1672-2353.2008.01.002

小鼠肝素酶H-2Kb限制性CTL表位的实验鉴定

基金项目: 国家自然科学基金
详细信息
  • 中图分类号: R730.5

Identification of H-2Kb-restricted CTL epitopes derived from Heparanase antigen

  • 摘要: 目的 实验鉴定H-2Kb限制性小鼠肝素酶(mHpa)CTL表位.方法 5条mHpa表位分别负载C57BL/6小鼠骨髓来源树突状细胞,并进一步诱导产生表位特异性的效应细胞,采用标准4 hCr释放试验检测效应细胞对不同靶细胞的免疫杀伤效应;采用ELISPOT检测效应细胞分泌IFN-γ的能力.结果 5条mHpa CTL表位中,仅mHpa398-405和mHpa519-526可以诱导小鼠产生特异性CTL.对同来源的B16黑色素瘤细胞、Lewis肺癌细胞和EL-4淋巴瘤细胞具有明显的免疫杀伤效应,而对H-2Kb阴性的P815肥大细胞瘤细胞不具有免疫杀伤效应,进一步研究发现,上述多肽特异性CTL对自体淋巴细胞和DC细胞不具有杀伤效应,另一方面,mHpa398-405和mHpa519-526还可促进效应细胞分泌IFN-γ的能力.结论 mH-pa398-405、mHpa519-526为小鼠肝素酶来源且受仟12Kb限制性CTL表位,小鼠体内可以诱导产生表位特异性的CTL反应.
  • Vlodavsky I, Friedmann Y, Elkin M. Mammalian heparanase:gene cloning, expression and function in tumor progression and metastasis [J]. Nature Medicine, 1999, (7):793.doi: 10.1038/10518.
    Hulett M D, Freeman C, Hamdod B J. Cloning of mammalian heparamse.an important enzyme in tumor invasion and metastasis [J]. Nature Medicine, 1999, (7):803.doi: 10.1038/10525.
    Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angingenesis [J]. International Journal of Biochemistry & Cell Biology, 2006, (12):2018.
    Cai Y G, Fang D C, Chen L. Dendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cens in vitro [J]. Tumour Biology, 2007(4):238.
    汤旭东, 万瑛, 陈婷, 熊震. 小鼠肝素酶H-2Kb限制性CTL表位预测及其MHC-I亲和力分析 [J]. 重庆医学, 2007(9):820.doi: 10.3969/j.issn.1671-8348.2007.09.018.
    Inaba K, lnaba M, Romani N. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyter/macmphage colony-stimuhtingfactor [J]. Journal of Experimental Medicine, 1992(6):1693.doi: 10.1084/jem.176.6.1693.
    Chen L, Liang G P, Tang X D. In vitm anti-tumor immune response induced by dendritic calls transfeeted with hTERT recombinant adenovirus [J]. Biochemical and Biophysical Research Communications, 2006(4):927.doi: 10.1016/j.bbrc.2006.10.165.
    Son Y I, Egawa S, Tatstani T. A novel bulk-culture method for generating mature dendritic ceils from mouse bone marrow cells [J]. Journal of Immunological Methods, 2002, (122):145.doi: 10.1016/S0022-1759(02)00013-3.
    lnaba K, Inaba M, Romzni N. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyter/macrophage colony-stimulatingfactor [J]. Journal of Experimental Medicine, 1992.176.
    Lider O, Mekori Y A, Miller T. Inhibition of T lymphoeyte heparamse by heparin prevents T cell migration and T cell-mediated immunity [J]. European Journal of Immunology, 1990(3):493.doi: 10.1002/eji.1830200306.
    李志宏, 杨仕明. 乙酰肝素酶与肿瘤转移研究进展 [J]. 癌症, 2005(9):1156.doi: 10.3321/j.issn:1000-467X.2005.09.026.
    segal N H, Blachere N E, Guevara-Patino J A. Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics [J]. Cancer Immunity, 2005.2.
    Mittendorf E A, Gurney J M, Storrer C E. Vaccination with a HER2/neu peptide induces intra-and inter-antigenic epitope spreading in patients with early stage breast cancer [J]. Surgery, 2006(3):407.doi: 10.1016/j.surg.2005.06.059.
    Jager E, Jager D, Knuth A. Clinical Pancer vaccine trials [J]. Current Opinion in Immunology, 2002(2):178.doi: 10.1016/S0952-7915(02)00318-7.
    Ueda Y, Shimizu K, Imh T. Induction of PeptideSpecific hranune Response in Patients with Primary Malignant Melanoma of the Esophagus after Immunotherapy Using Dendritic Cells Pulsed with MAGE Peptidea [J]. Japanese Journal of Clinical Oncology, 2007(2):140.doi: 10.1093/jjco/hyl136.
    Nava-Parada P, Fomi G, Knutson K L. Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneoua breast tumors [J]. Cancer Research, 2007(3):1326.doi: 10.1158/0008-5472.CAN-06-3290.
    杨仕明, 汤旭东, 陈婷. 肝素酶:一种新的广谱的肿瘤转移相关抗原在中晚期肿瘤免疫治疗中的作用研究进展 [J]. 世界华人消化杂志, 2007(8):849.doi: 10.3969/j.issn.1009-3079.2007.08.010.
    Zhang z H, Chen Y, Zhao H J. Silencing of Heparanase by siRNA Inhibits Tumor Metastasis and Angiogenesis of Human Breast Cancer In Vitro and In Vivo [J]. Cancer Biology and Therapy, 2007(4).doi: 10.4161/cbt.6.4.3888.
    Zhang Y, Li L, Wang Y. Downregulating the expression of heparanase inhibits the invasion, angingenesis and metastasis of htman hepatocellular carcinoma [J]. Biochem Biophys Rea Cornnlun, 2007.
    McKenzie E A. Heparanase:a target for drug discovery in cancer and inflammation [J]. British Journal of Pharmacology, 2007(1):1.doi: 10.1038/sj.bjp.0707182.
    Sommerfeldt N, Beckhove P, Ge Y. Heparanase:a new metastasis assooated antigen recognized in breast cancer patients by spontaneously indueed memory T lymphocyte [J]. Cancer Research, 2006, (15):7716.doi: 10.1158/0008-5472.CAN-05-2363.
    Nava-Parada P, Fomi G, Knutson K L, Pease L R Celis E. Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of sportaneous breast tumors [J]. Cancer Research, 2007(3):1326.doi: 10.1158/0008-5472.CAN-06-3290.
计量
  • 文章访问数:  160
  • HTML全文浏览量:  26
  • PDF下载量:  17
  • 被引次数: 0
出版历程
  • 发布日期:  2008-07-13

目录

    /

    返回文章
    返回